Long-term Efficacy and Safety of Ropeginterferon Alfa-2b under its HIDAT Regimen for the Treatment of Polycythemia Vera.
Suo S, Fu RF, Qin A Dr, Shao Z, Bai J, Zhou H, Xu N, Chen S, Zuo X, Du X, Duan M, Wang L, Li P, Zhang X, Zhang S, Wu D, Zhang J, Xiao Z, Zhang L, Jin J.
Suo S, et al. Among authors: fu rf.
Blood Adv. 2025 Oct 31:bloodadvances.2025017938. doi: 10.1182/bloodadvances.2025017938. Online ahead of print.
Blood Adv. 2025.
PMID: 41172233
No abstract available.